Purchase Order 75N91020P00336

<p>The National Cancer Institute issued a purchase order to Qiagen, LLC on December 18, 2020, for scientific equipment valued at $24,984.12, with completion required by January 31, 2021. Performance takes place in Germantown, Maryland. The order is priced on a firm fixed price basis.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,053 purchase order to Qiagen, LLC for service agreement work. Qiagen, a subsidiary of Qiagen N.V., will perform the services at its location in Bethesda, Maryland under the firm fixed price contract, which runs from September 1, 2023 through August 31, 2024. The award provides services to support the National Cancer Institute's research efforts as it works to prevent and cure cancer....

<p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC for $15,500.00 with an award date of March 13, 2020 and ultimate completion date of March 12, 2021. Performance occurs in Bethesda, Maryland. The order is priced firm fixed price with no set-aside designation. The specific commodities or services procured are not detailed in the source.</p>

The National Cancer Institute awarded a $24,731 firm fixed-price purchase order to Qiagen, LLC on August 12, 2021, for laboratory equipment with an ultimate completion date of October 10, 2021. This contract was issued without a set-aside designation and was to be performed in Germantown, Maryland, where Qiagen's U.S. subsidiary is headquartered. The award represents an administrative de-obligation of unexpended and expiring Fiscal Year 2021 funding in preparation for the September 30, 2026...

<p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC for $80,260 on March 28, 2019, with ultimate completion on April 14, 2021. No set-aside was used. The order covers molecular diagnostics products and related supplies, with firm fixed-price pricing. Performance occurs at Bethesda, Maryland.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,053 purchase order to Qiagen, LLC for maintenance agreement services. Qiagen, LLC is a division of Qiagen N.V., a global life sciences company, and will perform the services at its location in Bethesda, Maryland between August 2023 and August 2024 under firm fixed pricing. The award provides support for an existing Qiagen product or solution under a one-year period of performance...

Qiagen, LLC was awarded a firm fixed price purchase order valued at approximately $723,300 by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. Under this contract, Qiagen will provide clinical interpretation of genomic variants from large next-generation panel testing, whole exome sequencing, and whole transcriptome sequencing. Performance will take place in Germantown, Maryland over a two year period concluding...

<p>The National Institutes of Health Clinical Center issued a purchase order to Qiagen, LLC on August 4, 2017, for $12,830.65 under firm fixed price terms, with performance completion by August 10, 2017. Work is performed at Bethesda, Maryland. The order procures molecular diagnostics products and supplies, which are part of Qiagen's standard federal portfolio of DNA/RNA extraction kits, reagents, and laboratory consumables supporting biomedical research and clinical diagnostic operations.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC valued at $24,987.30 on March 30, 2020, for cell supplies to support experimental protocol studies treating patients with COVID-19. Place of performance is Germantown, Maryland. The order carries firm fixed price terms and is designated under the Coronavirus COVID-19 National Interest Action Code. Ultimate completion date is March 30, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for one QIAsymphony SP System valued at $93,067.38 on August 19, 2020. The instrument supports the National Cancer Institute's Cancer Center for Research Laboratory of Pathology at its Germantown, Maryland location. The order carries firm fixed pricing and ultimate completion was scheduled for September 20, 2020. No small business set-aside applied.</p>